Preventing Negative Reactions in First Time Blood Donors to Encourage Subsequent Blood Donations
NCT ID: NCT00302900
Last Updated: 2016-10-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
441 participants
INTERVENTIONAL
2006-01-31
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Efficiency of Hydration by Isotonic Solution in the Prevent of the Fainting Whole Blood Donors
NCT02075099
Effect of Dietary Salt Supplemantation in Vasovagal Syncope Prophylaxis: A Clinical Trial
NCT00465946
Improving Syncope Risk Stratification in Older Adults
NCT01802398
Practical Approaches to Care in Emergency Syncope
NCT04533425
Effect of Chronic Oral Hydration in Patients With Recurrent Unexplained Syncope
NCT00143754
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will enroll American Red Cross blood donors who have donated blood no more than twice previously. Participants will be randomly assigned to one of the following four groups: 1) pre-donation water consumption and muscle tensing exercise during donation; 2) pre-donation water consumption; 3) pre-donation muscle tensing exercise; or 4) no treatment. Participant reactions will be assessed at the time of donation by self-report and phlebotomist ratings, as well as by self-report 24 hours following the donation. Participants' subsequent donation history will be tracked for two years by reviewing the American Red Cross national donor database.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Pre-donation water and muscle tension during donation
Pre-Donation Water Consumption
Consumption of 500 ml of bottled water 30 minutes prior to donating
Muscle Tensing Exercise During Donation
Alternating leg lifts at 10-second intervals during donation
2
Pre-donation water
Pre-Donation Water Consumption
Consumption of 500 ml of bottled water 30 minutes prior to donating
3
Pre-donation muscle tension
Muscle Tensing Exercise Prior to Donation
Alternating leg lifts at 10-second intervals prior to insertion of the donation needle
4
Standard donation
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pre-Donation Water Consumption
Consumption of 500 ml of bottled water 30 minutes prior to donating
Muscle Tensing Exercise During Donation
Alternating leg lifts at 10-second intervals during donation
Muscle Tensing Exercise Prior to Donation
Alternating leg lifts at 10-second intervals prior to insertion of the donation needle
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Ohio University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christopher R. France, PhD
Role: PRINCIPAL_INVESTIGATOR
Ohio University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ohio University
Athens, Ohio, United States
American Red Cross Blood Services - Central Ohio Region
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
371
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.